Neuronal excitatory properties of human immunodeficiency virus type 1 Tat protein

Neuroscience

Volumn 82, Issue 1, 1997, Pages 97-106

  Cheng, J ^a   Nath, A ^a   Knudsen, B ^a   Hochman, S ^a   Geiger, J D ^a   Ma, M ^a   Magnuson, D S K ^a  

^a UNIVERSITY OF MANITOBA   (Canada)

Author keywords

Calcium; Depolarization; HIV 1; Human; Neuron; Tat

Indexed keywords

CALCIUM; GLYCOPROTEIN GP 120; TETRODOTOXIN; TRANSACTIVATOR PROTEIN; VIRUS PROTEIN;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; DEPOLARIZATION; FETUS; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; NERVE CELL STIMULATION; NEUROTOXICITY; NONHUMAN; PATCH CLAMP; PRIORITY JOURNAL; RAT;

ANIMALS; CALCIUM; ELECTRIC STIMULATION; ELECTROPHYSIOLOGY; GENE PRODUCTS, TAT; HIPPOCAMPUS; HIV-1; HUMANS; MEMBRANE POTENTIALS; NEURONS; PATCH-CLAMP TECHNIQUES; RATS; RATS, SPRAGUE-DAWLEY; STIMULATION, CHEMICAL; TETRODOTOXIN;

EID: 0030962775     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-4522(97)00174-7     Document Type: Article

References (40)

1. Ascher P., Nowak L. Quisqualate- and kainate-activated channels in mouse central neurones in culture. J. Physiol., Lond. 399:1988;227-245.
2. + exchange in astrocytes. J. biol. Chem. 269:1994;13811-13816.
3. 2+ entry via AMPA/KA receptors and excitotoxicity in cultured cerebellar Purkinje cells. J. Neurosci. 14:1994;187-197.
4. Brorson J. R., Manzolillo P. A., Gibbons S. J., Miller R. J. AMPA receptor desensitization predicts the selective vulnerability of cerebellar Purkinje cells to excitotoxicity. J. Neurosci. 15:1995;4515-4524.
5. Choi D. W. Calcium-mediated neurotoxicity: relationship to specific channel types and role in ischemic damage. Trends Neurosci. 11:1988;465-469.
6. Choi D. W. Excitotoxic cell death. J. Neurobiol. 23:1992;1261-1276.
7. Choi D. W. Calcium and excitotoxic neuronal injury. Ann. N. Y. Acad. Sci. 747:1994;162-171.
8. Diop A. G., Lesort M., Esclaire F., Sindou P., Couratier P., Hugon J. Tetrodotoxin blocks HIV coat protein (gp120) toxicity in primary neuronal cultures. Neurosci. Lett. 165:1994;187-190.
9. Ensoli B., Buonaguro L., Barillari G., Fiorelli V., Gendelman R., Morgan R. A., Wingfield P., Gallo R. C. Release, uptake, and effects of extracellular human immunodeficiency virus type 1 Tat protein on cell growth and viral transactivation. J. Virol. 67:1993;277-287.
10. Epstein L. G., Gendelman H. E. Human immunodeficiency virus type 1 infection of the nervous system: pathogenic mechanisms. Ann. Neurol. 33:1993;429-436.
11. Feinberg M. B., Baltimore D., Frankel A. D. The role of Tat in the human immunodeficiency virus life cycle indicates a primary effect on transcriptional elongation. Proc. natn. Acad. Sci. U.S.A. 88:1991;4045-4049.
12. Garthwaite G., Garthwaite J. AMPA neurotoxicity in rat cerebellar and hippocampal slices: histological evidence for three mechanisms. Eur. J. Neurosci. 3:1991;715-728.
13. Gray F., Haug H., Chimelli L., Geny C., Gaston A., Scaravilli F., Budka H. Prominent cortical atrophy with neuronal loss as correlate of human immunodeficiency virus encephalopathy. Acta. neuropath., Berlin. 82:1991;229-233.
14. 2+ accumulation in cortical cell culture correlates with subsequent neuronal degeneration. J. Neurosci. 13:1993;1993-2000.
15. Hayman M., Arbuthnott G., Harkiss G., Brace H., Filippi P., Philippon V., Thomson D., Vigne R., Wright A. Neurotoxicity of peptide analogues of the transactivating protein tat from Maedi-Visna virus and human immunodeficiency virus. Neuroscience. 53:1993;1-6.
16. 2+ permeability of KA-AMPA-gated glutamate receptor channels depends on subunit composition. Science. 252:1991;851-853.
17. Iino M., Ozawa S., Tsuzuki K. Permeation of calcium through excitatory amino acid receptor channels in cultured rat hippocampal neurones. J. Physiol., Lond. 424:1990;151-165.
18. Jonas P., Sakmann B. Glutamate receptor channels in isolated patches from CA1 and CA3 pyramidal cells of rat hippocampal slices. J. Physiol., Lond. 455:1992;143-171.
19. Ketzler S., Weis S., Haug H., Budka H. Loss of neurons in the frontal cortex in AIDS brains. Acta neuropath., Berlin. 80:1990;92-94.
20. Lipton S. A. Human immunodeficiency virus-infected macrophages, gp120, and N-methyl-D-aspartate receptor-mediated neurotoxicity. Ann. Neurol. 33:1993;227-228.
21. Lipton S. A. Neuronal injury associated with HIV-1 and potential treatment with calcium-channel and NMDA antagonists. Devl Neurosci. 16:1994;145-151.
22. Lipton S. A., Gendelman H. E. Dementia associated with the acquired immunodeficiency syndrome. New Engl. J. Med. 332:1995;934-940.
23. Magnuson D. S. K., Knudsen B. E., Geiger J. D., Brownstone R. M., Nath A. Human immunodeficiency virus type 1 tat activates non-N-methyl-D-aspartate excitatory amino acid receptors and causes neurotoxicity. Ann. Neurol. 37:1995;373-380.
24. Masliah E., Ge N., Achim C. L., Hansen L. A., Wiley C. A. Selective neuronal vulnerability in HIV encephalitis. J. Neuropath. exp. Neurol. 51:1992;585-593.
25. Masliah E., Achim C. L., Ge N., De Teresa R., Wiley C. A. Cellular neuropathology in HIV encephalitis. Res. Publs Ass. Res. nerv. ment. Dis. 72:1994;119-131.
26. Mayer M. L., Westbrook G. L. Mixed-agonist action of excitatory amino acids on mouse spinal cord neurones under voltage clamp. J. Physiol., Lond. 354:1984;29-53.
27. 2+ influx into striatal neurons by kainic acid. J. Pharmac. exp. Ther. 249:1989;184-194.
28. Nath A., Psooy K., Knudsen B., Magnuson D. S. K., Haughey N., Geiger J. D. Identification of a human immunodeficiency virus type-1 epitope that is neuroexcitatory and neurotoxic. J. Virol. 70:1996;1475-1480.
29. Navia B. A., Cho E. S., Petito C. K., Price R. W. The AIDS dementia complex. II. Neuropathology. Ann. Neurol. 19:1986;525-535.
30. Philippon V., Vellutini C., Gambarelli D., Harkiss G., Arbuthnott G., Metzger D., Roubin R., Filippi P. The basic domain of the lentiviral Tat protein is responsible for damages in mouse brain: involvement of cytokines. Virology. 205:1994;519-529.
31. Price R. W., Brew B., Sidtis J., Rosenblum M., Scheck A. C., Cleary P. The brain in AIDS: central nervous system HIV-1 infection and AIDS dementia complex. Science. 239:1988;586-592.
32. Rothman S. M., Olney J. W. Glutamate and the pathophysiology of hypoxic-ischemic brain damage. Ann. Neurol. 19:1986;105-111.
33. Rothstein J. D., Jin L., Dykes-Hoberg M., Kuncl R. W. Chronic inhibition of glutamate uptake produces a model of slow neurotoxicity. Proc. natn. Acad. Sci. U.S.A. 90:1993;6591-6596.
34. Sabatier J. M., Vives E., Mabrouk K., Benjouad A., Rochat H., Duval A., Hue B., Bahraoui E. Evidence for neurotoxic activity of tat from human immunodeficiency virus type 1. J. Virol. 65:1991;961-967.
35. Sah D. W. Y. Human fetal central neurons in culture: voltage- and ligand-gated currents. J. Neurophysiol. 74:1995;1889-1899.
36. Tardieu M., Hery C., Peudenier S., Boespflug O., Montagnier L. Human immunodeficiency virus type 1-infected monocytic cells can destroy human neural cells after cell-to-cell adhesion. Ann. Neurol. 32:1992;11-17.
37. Tong G., Shepherd D., Jahr C. E. Synaptic desensitization of NMDA receptors by calcineurin. Science. 267:1995;1510-1512.
38. Twyman R. E., Gahring L. C., Spiess J., Rogers S. W. Glutamate receptor antibodies activate a subset of receptors and reveal an agonist binding site. Neuron. 14:1995;755-762.
39. Weeks B. S., Lieberman D. M., Johnson B., Roque E., Green M., Loewenstein P., Oldfield E. H., Kleinman H. K. Neurotoxicity of the human immunodeficiency virus type 1 Tat transactivator to PC12 cells requires the Tat amino acid 49-58 basic domain. J. Neurosci. Res. 42:1995;34-40.
40. Wiley C. A., Masliah E., Morey M., Lemere C., DeTeresa R., Grafe M., Hansen L., Terry R. Neocortical damage during HIV infection. Ann. Neurol. 29:1991;651-657.